vertigo and tirzepatide 18 Possible Side Effects of (Mounjaro, Zepbound) How to Manage Tirzepatide Dizziness

Here is what to actually check

Phase 3 data from the TRIUMPH-4 study, released in December of last year, showed 28.7% average body weight loss at the 12 mg dose over 68 weeks

Left unmanaged, it increases the risk of heart attack, stroke, kidney disease, and vascular dementia

Alterations in the normal function of excitatory amino acid carrier 1 affect cysteine transport and GSH synthesis impairing zinc homeostasis (the thiol group of GSH can function as a principal Zn 2+ chelator for the maintenance of Zn 2+ homeostasis in neurons) and oxidative stress, enhancing susceptibility to ischemia-induced neuronal cell death in the hippocampus (162164)